Your browser doesn't support javascript.
loading
Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
Kroon, M W; Kemp, E Helen; Wind, B S; Krebbers, G; Bos, J D; Gawkrodger, D J; Wolkerstorfer, A; van der Veen, J P Wietze; Luiten, R M.
Affiliation
  • Kroon MW; Department of Dermatology, Netherlands Institute for Pigment Disorders, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.w.kroon@amc.uva.nl
J Eur Acad Dermatol Venereol ; 27(9): 1172-5, 2013 Sep.
Article in En | MEDLINE | ID: mdl-22404127
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Vitiligo / Melanocytes / Antigens Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2013 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Vitiligo / Melanocytes / Antigens Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2013 Document type: Article Affiliation country: